Orencia vs. Sulindac: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Orencia and Sulindac. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 172,387 people who take Orencia and Sulindac, and is updated regularly.
What is Orencia?
Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. eHealthMe is studying from 135,415 Orencia users. Check the latest studies of Orencia.
What is Sulindac?
Sulindac has active ingredients of sulindac. It is often used in rheumatoid arthritis. eHealthMe is studying from 3,824 Sulindac users. Check the latest studies of Sulindac.
172,387 people who take Orencia and Sulindac are studied.

Drugs being compared in this study:
- Orencia (abatacept)
- Sulindac (sulindac)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Orencia:
- not at all: 8.73 %
- somewhat: 24.21 %
- moderate: 31.35 %
- high: 24.6 %
- very high: 11.11 %
Sulindac:
- not at all: 13.91 %
- somewhat: 22.61 %
- moderate: 40.87 %
- high: 14.78 %
- very high: 7.83 %
Want to compare Orencia with Sulindac?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Orencia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sulindac:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on abatacept and sulindac (the active ingredients of Orencia and Sulindac, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lamisil cause Weight Increased? - 17 seconds ago
- Could Escitalopram cause Abdominal Pain Lower? - 20 seconds ago
- Drug interactions of Bisoprolol Fumarate and Econazole Nitrate - 26 seconds ago
- Could Adenosine cause Bone Loss? - 33 seconds ago
- Could Pulmicort cause Allergic Granulomatous Angiitis? - 45 seconds ago
- Could Nurtec Odt cause Overdose? - 49 seconds ago
- Could Doral cause Joint Pain? - a minute ago
- Could Aspirin cause Coughing Up Blood? - a minute ago
- Could Onfi cause Drop Attacks? - a minute ago
- Could Valcyte cause Diabetes? - a minute ago